[Clinical significance of HLA monitoring in carcinoma of the nasopharynx].
Síbl
O
O
Ivasková
E
E
Roubalová
K
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000956:Antigens, Viral / Q000032:analysis; D036022:Capsid Proteins; D002277:Carcinoma / Q000276:immunology*; D005260:Female; D006680:HLA Antigens / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000276:immunology*
D000956:Antigens, Viral; D036022:Capsid Proteins; C041788:Epstein-Barr viral capsid antigen; C033305:Epstein-Barr virus early antigen; D006680:HLA Antigens
Klinický význam sledování HLA u karcinomů nosohltanu.